EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Semaglutide-associated drug-induced liver injury: a case report and review of the literature

Ian Kempster, Darren Fernandes iD, Mohammed S Saeed, Caroline Sharratt, Sara Benfield

Oxford Medical Case Reports · 15.09.2025 · 2025 (9)

DOI: 10.1093/omcr/omaf177 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Oxford Medical Case Reports, online erschienen am 28.09.2025. Verfasst von Ian Kempster und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Gastroenterology, Sherwood Forest Hospitals NHS Trust, Mansfield Road, Sutton-in-Ashfield, NG17 4JL, United Kingdom. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1RA) used to manage type 2 diabetes and, since 2021, for weight loss in individuals with obesity or weight-related comorbidities. It works by enhancing insulin secretion, delaying gastric emptying and reducing appetite. Common side effects include hypoglycaemia, gastrointestinal disturbances, nausea, weight loss and cholelithiasis. While some studies have noted an association with acute kidney injury, reports of liver injury are rare. We present a rare case of drug-induced liver injury in a middle-aged female, associated with transient liver failure after semaglutide use. She presented one month after starting the medication with rapidly worsening liver function tests. Investigations, including a non-invasive liver screen, viral studies, ultrasound and CT imaging, revealed no clear cause. A liver biopsy supported the diagnosis of drug-induced liver injury. The patient improved with supportive treatment and withdrawal of semaglutide. This case underscores the importance of clinician awareness given its increasing, and often unregulated, use for weight loss.

Schlagwörter

Stichwörter der Autor:innen

GLP-1 receptor agonistsSemaglutideacute liver failuredrug induced liver injury

Autor:innen und Institutionen

  • The Department of Gastroenterology, Sherwood Forest Hospitals NHS Trust, Mansfield Road, Sutton-in-Ashfield, NG17 4JL, United Kingdom.
  • The Department of Histopathology, Sherwood Forest Hospitals NHS Trust, Mansfield Road, Sutton-in-Ashfield, NG17 4JL, United Kingdom.

ORCID-Profile: Darren Fernandes

Zitieren

APA

Kempster, I., Fernandes, D., Saeed, M. S., Sharratt, C., & Benfield, S. (2025). Semaglutide-associated drug-induced liver injury: a case report and review of the literature. Oxford Medical Case Reports, 2025(9). https://doi.org/10.1093/omcr/omaf177

Vancouver

Kempster I, Fernandes D, Saeed MS, Sharratt C, Benfield S. Semaglutide-associated drug-induced liver injury: a case report and review of the literature. Oxford Medical Case Reports. 2025;2025(9). doi:10.1093/omcr/omaf177

BibTeX
@article{Kempster2025,
  author = {Kempster, Ian and Fernandes, Darren and Saeed, Mohammed S and Sharratt, Caroline and Benfield, Sara},
  title = {Semaglutide-associated drug-induced liver injury: a case report and review of the literature},
  journal = {Oxford Medical Case Reports},
  year = {2025},
  volume = {2025},
  number = {9},
  doi = {10.1093/omcr/omaf177}
}
Kostenlos starten →